Cerespir is a operator of a biotechnology company intended to treat neurodegenerative disorders. The company focuses on a novel class of pharmacological agents known as AICD inhibitors and they act by preventing the destructive cycle of neuroinflammation and neurodegeneration which is initiated by chronic oxidative stress, enabling physicians to